Quinta-Analytica will be presenting its robust and versatile LC/MS/MS method during upcoming compliance meeting Nitrosamine Impurities organized by European Compliance Academy on February 18th, 2020 in Frankfurt.
Join us in Frankfurt on February 18th, 2020 to watch Pavel from our team present Quinta-Analytica’s robust and versatile LC/MS/MS detection methods at the European Compliance Academy’s Nitrosamine Impurities urgent compliance meeting.
As one of the biggest challenges to the pharma industry today, and with all Marketing Authorization Holders now obligated to evaluate the risks of their products containing chemically synthesized APIs, its’ clear that potential Nitrosamine contamination in drug substances is seen as a real risk.
Qunita-Analytica’s detection methods are based on isotopically labeled standards, and are customized to each specific scenario. Already proven to be applicable on a broad range of nitrosamines and matrixes, and capable of reaching LOQ down to 20 ppb, our team are able to offer highly sensitive testing beyond the general scope of Sartans, Ranitidine and Metformin and support our clients with specific cases including customer-specific APIs, excipients, semi-finished products and more.
To learn more about how we can help your organization with supply continuity, contact Pavel from our commercial team at email@example.com.
More information about the Nitrosamine Impurities event can be found here. If you’re going to be in the are or atending the event, please let us know and we’ll be pleased to meet with you!
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency